@erosolaraijs/cure 2.4.0 → 2.5.1
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- package/README.md +187 -272
- package/dist/bin/cure.js +1 -1
- package/dist/tools/index.d.ts.map +1 -1
- package/dist/tools/index.js +1702 -0
- package/dist/tools/index.js.map +1 -1
- package/package.json +1 -1
- package/src/bin/cure.ts +1 -1
- package/src/tools/index.ts +1873 -0
package/README.md
CHANGED
|
@@ -1,6 +1,6 @@
|
|
|
1
1
|
# Cure
|
|
2
2
|
|
|
3
|
-
AI-powered precision oncology platform for cancer treatment, clinical decision support, and
|
|
3
|
+
AI-powered precision oncology and comprehensive health platform for cancer treatment, clinical decision support, and wellness optimization.
|
|
4
4
|
|
|
5
5
|
```
|
|
6
6
|
██████╗██╗ ██╗██████╗ ███████╗
|
|
@@ -20,170 +20,215 @@ npm install -g @erosolaraijs/cure
|
|
|
20
20
|
## Quick Start
|
|
21
21
|
|
|
22
22
|
```bash
|
|
23
|
-
# Launch interactive
|
|
23
|
+
# Launch interactive mode
|
|
24
24
|
cure
|
|
25
25
|
|
|
26
|
-
#
|
|
27
|
-
|
|
28
|
-
|
|
26
|
+
# Or run specific commands directly
|
|
27
|
+
cure --selftest # Run health checks
|
|
28
|
+
cure --tools # List all 70+ health tools
|
|
29
|
+
cure --tool=preventive-screening # Run a specific tool
|
|
30
|
+
cure --cure --cancer=NSCLC --stage=IV --mutations=KRAS_G12C
|
|
31
|
+
```
|
|
32
|
+
|
|
33
|
+
## Interactive Mode
|
|
34
|
+
|
|
35
|
+
Just run `cure` to enter interactive mode:
|
|
29
36
|
|
|
30
|
-
# Generate a cure protocol
|
|
31
|
-
/cure NSCLC IV KRAS_G12C
|
|
32
37
|
```
|
|
38
|
+
$ cure
|
|
33
39
|
|
|
34
|
-
|
|
40
|
+
██████╗██╗ ██╗██████╗ ███████╗
|
|
41
|
+
██╔════╝██║ ██║██╔══██╗██╔════╝
|
|
42
|
+
...
|
|
35
43
|
|
|
36
|
-
|
|
44
|
+
cure> /help # Show all commands
|
|
45
|
+
cure> /tools # List all 70+ health tools
|
|
46
|
+
cure> /tool preventive-screening # Run preventive screening
|
|
47
|
+
cure> /cure Lung IV EGFR # Generate cure protocol
|
|
48
|
+
cure> What treatments are available for KRAS G12C lung cancer?
|
|
49
|
+
```
|
|
37
50
|
|
|
38
|
-
|
|
39
|
-
- Treatment recommendations based on cancer type, stage, and biomarkers
|
|
40
|
-
- Drug mechanism explanations
|
|
41
|
-
- Clinical trial guidance
|
|
42
|
-
- Biomarker interpretation
|
|
51
|
+
## Features
|
|
43
52
|
|
|
44
|
-
|
|
45
|
-
|
|
46
|
-
|
|
53
|
+
### 70+ Health & Wellness Tools
|
|
54
|
+
|
|
55
|
+
Run `/tools` to see all available tools, or `/tool <id>` to run a specific tool.
|
|
56
|
+
|
|
57
|
+
#### Cancer & Oncology Tools
|
|
58
|
+
| Tool | Description |
|
|
59
|
+
|------|-------------|
|
|
60
|
+
| `selftest` | Core capability smoke tests |
|
|
61
|
+
| `validate` | Retrospective validation |
|
|
62
|
+
| `cancer-core` | Treatment dataset summary |
|
|
63
|
+
| `cancer-analyze` | Patient analysis |
|
|
64
|
+
| `cancer-plan` | Treatment planning |
|
|
65
|
+
| `cancer-cure` | Cure protocol generation |
|
|
66
|
+
| `cancer-discover` | Drug target discovery |
|
|
67
|
+
| `universal-cure` | Universal cancer cure engine |
|
|
68
|
+
| `global-coverage` | Global guideline coverage |
|
|
69
|
+
| `treatment-sequencing` | Next-line therapy |
|
|
70
|
+
| `precision-medicine` | Precision medicine report |
|
|
71
|
+
| `emerging-therapeutics` | Emerging therapies |
|
|
72
|
+
| `multimodal-oncology` | Multimodal oncology |
|
|
73
|
+
| `special-populations` | Pediatric/geriatric care |
|
|
74
|
+
| `resistance-management` | Resistance analysis |
|
|
75
|
+
| `cure-verification` | Cure status verification |
|
|
76
|
+
| `cure-validation` | Coverage validation |
|
|
77
|
+
| `clinical-trial-matching` | Trial matching |
|
|
78
|
+
| `palliative-care` | Pain and opioid management |
|
|
79
|
+
| `emergency-oncology` | Oncology emergencies |
|
|
80
|
+
| `survivorship-care` | Survivorship planning |
|
|
81
|
+
|
|
82
|
+
#### Preventive Health Tools
|
|
83
|
+
| Tool | Description |
|
|
84
|
+
|------|-------------|
|
|
85
|
+
| `preventive-screening` | Age/gender-specific screenings |
|
|
86
|
+
| `immunization-schedule` | Vaccine recommendations |
|
|
87
|
+
| `genetic-risk` | Hereditary condition assessment |
|
|
88
|
+
| `skin-health` | Skin cancer prevention |
|
|
89
|
+
|
|
90
|
+
#### Chronic Disease Management
|
|
91
|
+
| Tool | Description |
|
|
92
|
+
|------|-------------|
|
|
93
|
+
| `cardiovascular-risk` | ASCVD/Framingham risk |
|
|
94
|
+
| `diabetes-management` | Diabetes care |
|
|
95
|
+
| `hypertension-management` | Blood pressure management |
|
|
96
|
+
| `kidney-health` | CKD screening/staging |
|
|
97
|
+
| `liver-health` | Liver disease assessment |
|
|
98
|
+
| `respiratory-health` | COPD/asthma evaluation |
|
|
99
|
+
| `thyroid-screening` | Thyroid disorders |
|
|
100
|
+
| `bone-health` | Osteoporosis assessment |
|
|
101
|
+
|
|
102
|
+
#### Mental Health & Wellness
|
|
103
|
+
| Tool | Description |
|
|
104
|
+
|------|-------------|
|
|
105
|
+
| `mental-health-screening` | Depression/anxiety screening |
|
|
106
|
+
| `cognitive-screening` | Dementia risk assessment |
|
|
107
|
+
| `sleep-assessment` | Sleep disorders |
|
|
108
|
+
| `substance-screening` | Alcohol/tobacco/drug screening |
|
|
109
|
+
| `stress-management` | Stress coping strategies |
|
|
110
|
+
|
|
111
|
+
#### Nutrition & Lifestyle
|
|
112
|
+
| Tool | Description |
|
|
113
|
+
|------|-------------|
|
|
114
|
+
| `nutrition-assessment` | Dietary recommendations |
|
|
115
|
+
| `exercise-prescription` | Exercise guidelines |
|
|
116
|
+
| `weight-management` | Obesity management |
|
|
117
|
+
| `longevity-assessment` | Healthy aging strategies |
|
|
118
|
+
| `health-optimization` | Comprehensive wellness |
|
|
119
|
+
|
|
120
|
+
#### Specialized Care
|
|
121
|
+
| Tool | Description |
|
|
122
|
+
|------|-------------|
|
|
123
|
+
| `sexual-health` | STI screening, contraception |
|
|
124
|
+
| `infectious-disease` | HIV, hepatitis, TB screening |
|
|
125
|
+
| `autoimmune-screening` | Autoimmune markers |
|
|
126
|
+
| `allergy-assessment` | Allergy testing |
|
|
127
|
+
| `pain-management` | Chronic pain options |
|
|
128
|
+
| `medication-review` | Polypharmacy review |
|
|
129
|
+
| `fall-risk` | Fall risk assessment |
|
|
130
|
+
| `functional-status` | ADL/IADL assessment |
|
|
131
|
+
|
|
132
|
+
#### Life Stage Care
|
|
133
|
+
| Tool | Description |
|
|
134
|
+
|------|-------------|
|
|
135
|
+
| `pediatric-wellness` | Child development |
|
|
136
|
+
| `prenatal-care` | Pregnancy care |
|
|
137
|
+
| `menopause-management` | Menopause symptoms |
|
|
138
|
+
| `prostate-health` | Prostate screening |
|
|
139
|
+
|
|
140
|
+
#### Specialized Settings
|
|
141
|
+
| Tool | Description |
|
|
142
|
+
|------|-------------|
|
|
143
|
+
| `travel-health` | Travel vaccines/malaria |
|
|
144
|
+
| `occupational-health` | Workplace hazards |
|
|
145
|
+
| `environmental-health` | Environmental exposures |
|
|
146
|
+
| `vision-screening` | Eye health |
|
|
147
|
+
| `hearing-screening` | Audiological care |
|
|
148
|
+
| `dental-health` | Oral health |
|
|
149
|
+
|
|
150
|
+
### AI Chat
|
|
151
|
+
|
|
152
|
+
Chat with an AI oncologist using xAI Grok or OpenAI GPT-5.1:
|
|
47
153
|
|
|
48
|
-
|
|
154
|
+
```bash
|
|
155
|
+
cure> /model openai
|
|
156
|
+
cure> /key YOUR_API_KEY
|
|
157
|
+
cure> What is the best treatment for HER2+ breast cancer?
|
|
158
|
+
```
|
|
49
159
|
|
|
50
160
|
### Comprehensive Cancer Coverage
|
|
51
161
|
|
|
52
162
|
| Category | Coverage |
|
|
53
163
|
|----------|----------|
|
|
54
|
-
| Cancer Types | 200+ types and
|
|
164
|
+
| Cancer Types | 200+ types and subtypes |
|
|
55
165
|
| Biomarkers | 500+ actionable targets |
|
|
56
|
-
| Protocols |
|
|
57
|
-
|
|
|
58
|
-
| Special Circumstances | Pregnancy, transplant, autoimmune, HIV |
|
|
59
|
-
| Stages | Localized, locally advanced, metastatic, recurrent |
|
|
60
|
-
|
|
61
|
-
### Core Capabilities
|
|
62
|
-
|
|
63
|
-
#### Patient Analysis (`/analyze`)
|
|
64
|
-
- Genomic profiling and biomarker assessment
|
|
65
|
-
- Risk stratification and survival prediction
|
|
66
|
-
- Treatment response modeling
|
|
67
|
-
- MSI/TMB/HRD status analysis
|
|
68
|
-
|
|
69
|
-
#### Treatment Planning (`/plan`)
|
|
70
|
-
- NCCN, ESMO, ASCO protocol integration
|
|
71
|
-
- Personalized treatment recommendations
|
|
72
|
-
- Multi-modality planning (surgery, radiation, systemic)
|
|
73
|
-
- Timeline and monitoring schedules
|
|
74
|
-
|
|
75
|
-
#### Cure Protocol Generation (`/cure`)
|
|
76
|
-
- Comprehensive cure strategies by cancer type and stage
|
|
77
|
-
- Drug target prioritization with evidence levels
|
|
78
|
-
- Immunotherapy protocol matching
|
|
79
|
-
- Projected outcomes (response rate, 5-year survival, cure confidence)
|
|
80
|
-
|
|
81
|
-
#### Drug Target Discovery (`/discover`)
|
|
82
|
-
- AI-driven target identification
|
|
83
|
-
- Evidence-based prioritization (FDA-approved, clinical trials, preclinical)
|
|
84
|
-
- Pathway analysis
|
|
85
|
-
- Approved drug matching
|
|
86
|
-
|
|
87
|
-
#### Clinical Trial Matching (`/trials`)
|
|
88
|
-
- ClinicalTrials.gov integration
|
|
89
|
-
- Biomarker-based eligibility matching
|
|
90
|
-
- Location-aware search
|
|
91
|
-
- Phase and status filtering
|
|
92
|
-
|
|
93
|
-
#### Drug Safety (`/safety`)
|
|
94
|
-
- Drug-drug interaction checking
|
|
95
|
-
- Black box warning alerts
|
|
96
|
-
- QT prolongation risk assessment
|
|
97
|
-
- Pharmacogenomic considerations (DPYD, UGT1A1, TPMT/NUDT15)
|
|
98
|
-
|
|
99
|
-
#### ML Outcome Prediction (`/predict`)
|
|
100
|
-
- Response prediction (CR, PR, SD, PD)
|
|
101
|
-
- Survival estimates (PFS, OS with confidence intervals)
|
|
102
|
-
- Toxicity risk assessment
|
|
103
|
-
- Resistance prediction
|
|
166
|
+
| Protocols | 154+ (NCCN, ESMO, ASCO, FDA) |
|
|
167
|
+
| Drug Targets | 185+ with approved therapies |
|
|
104
168
|
|
|
105
169
|
### EHR Integration
|
|
106
170
|
|
|
107
|
-
Connect to hospital systems via HL7 FHIR R4:
|
|
108
|
-
|
|
109
171
|
```bash
|
|
110
|
-
/ehr connect epic
|
|
111
|
-
/ehr connect cerner
|
|
172
|
+
cure> /ehr connect epic
|
|
173
|
+
cure> /ehr connect cerner
|
|
112
174
|
```
|
|
113
175
|
|
|
114
|
-
|
|
115
|
-
- Epic
|
|
116
|
-
- Cerner
|
|
176
|
+
### Genomic Platforms
|
|
117
177
|
|
|
118
|
-
|
|
119
|
-
-
|
|
120
|
-
-
|
|
121
|
-
- Biomarker results
|
|
122
|
-
- Treatment history
|
|
123
|
-
- Medication records
|
|
124
|
-
|
|
125
|
-
### Genomic Platform Integration
|
|
126
|
-
|
|
127
|
-
```bash
|
|
128
|
-
/genomics platforms
|
|
129
|
-
```
|
|
130
|
-
|
|
131
|
-
**Supported Platforms:**
|
|
132
|
-
- **Foundation Medicine** (FoundationOne CDx)
|
|
133
|
-
- **Guardant Health** (Guardant360, GuardantOMNI)
|
|
134
|
-
- **Tempus** (xT, xF, xR)
|
|
135
|
-
|
|
136
|
-
**Analysis Types:**
|
|
137
|
-
- Somatic variant detection
|
|
138
|
-
- Copy number alterations
|
|
139
|
-
- Gene fusions
|
|
140
|
-
- MSI/TMB analysis
|
|
141
|
-
- Therapy matching
|
|
142
|
-
|
|
143
|
-
### HIPAA Compliance
|
|
144
|
-
|
|
145
|
-
- End-to-end encryption
|
|
146
|
-
- PHI masking and de-identification
|
|
147
|
-
- Audit logging with 7-year retention
|
|
148
|
-
- Role-based access control
|
|
149
|
-
- Consent management
|
|
178
|
+
- Foundation Medicine (FoundationOne CDx)
|
|
179
|
+
- Guardant Health (Guardant360)
|
|
180
|
+
- Tempus (xT, xF, xR)
|
|
150
181
|
|
|
151
182
|
## CLI Commands
|
|
152
183
|
|
|
153
|
-
###
|
|
184
|
+
### Quick Commands
|
|
154
185
|
| Command | Description |
|
|
155
186
|
|---------|-------------|
|
|
156
|
-
| `/
|
|
157
|
-
| `/
|
|
158
|
-
| `/
|
|
187
|
+
| `/help` | Show all commands |
|
|
188
|
+
| `/tools` | List all 70+ health tools |
|
|
189
|
+
| `/tool <id>` | Run a specific tool |
|
|
190
|
+
| `/tool all` | Run all tools |
|
|
191
|
+
| `/selftest` | Run self-tests |
|
|
159
192
|
|
|
160
|
-
###
|
|
161
|
-
| Command | Description |
|
|
162
|
-
|---------|-------------|
|
|
163
|
-
| `/analyze [patient]` | Analyze patient data |
|
|
164
|
-
| `/plan [patient]` | Design treatment plan |
|
|
165
|
-
| `/cure [cancer] [stage] [mutations...]` | Generate cure protocol |
|
|
166
|
-
| `/discover [gene] [cancer]` | Drug target discovery |
|
|
167
|
-
| `/trials [cancer] [biomarkers...]` | Find clinical trials |
|
|
168
|
-
| `/safety [drug1] [drug2...]` | Check drug interactions |
|
|
169
|
-
| `/predict [patient]` | ML outcome predictions |
|
|
170
|
-
|
|
171
|
-
### System Commands
|
|
193
|
+
### Cancer Commands
|
|
172
194
|
| Command | Description |
|
|
173
195
|
|---------|-------------|
|
|
174
|
-
| `/
|
|
175
|
-
| `/
|
|
176
|
-
| `/
|
|
177
|
-
| `/
|
|
178
|
-
| `/
|
|
179
|
-
| `/
|
|
180
|
-
|
|
181
|
-
|
|
196
|
+
| `/analyze [patient]` | Analyze patient |
|
|
197
|
+
| `/plan [patient]` | Treatment plan |
|
|
198
|
+
| `/cure [cancer] [stage] [mutations...]` | Cure protocol |
|
|
199
|
+
| `/discover [gene] [cancer]` | Drug discovery |
|
|
200
|
+
| `/trials [cancer] [biomarkers...]` | Clinical trials |
|
|
201
|
+
| `/safety [drug1] [drug2...]` | Drug interactions |
|
|
202
|
+
| `/predict [patient]` | ML predictions |
|
|
203
|
+
|
|
204
|
+
### AI Commands
|
|
182
205
|
| Command | Description |
|
|
183
206
|
|---------|-------------|
|
|
184
|
-
| `/
|
|
185
|
-
| `/
|
|
186
|
-
| `/
|
|
207
|
+
| `/key [provider] [key]` | Set API key |
|
|
208
|
+
| `/model [xai\|openai]` | Switch AI provider |
|
|
209
|
+
| `/clear` | Clear conversation |
|
|
210
|
+
|
|
211
|
+
## Command Line Usage
|
|
212
|
+
|
|
213
|
+
```bash
|
|
214
|
+
# Run tools directly
|
|
215
|
+
cure --selftest
|
|
216
|
+
cure --tools
|
|
217
|
+
cure --tool=preventive-screening
|
|
218
|
+
cure --tool=cardiovascular-risk
|
|
219
|
+
|
|
220
|
+
# Cancer commands
|
|
221
|
+
cure --cure --cancer=NSCLC --stage=IV --mutations=KRAS_G12C,TP53
|
|
222
|
+
cure --trials --cancer=Melanoma --biomarkers=BRAF_V600E
|
|
223
|
+
cure --safety --drugs=pembrolizumab,ipilimumab
|
|
224
|
+
cure --analyze-patient --patient=P001 --genomics
|
|
225
|
+
cure --drug-discovery --target=BRAF --cancer=Melanoma
|
|
226
|
+
|
|
227
|
+
# System
|
|
228
|
+
cure --status
|
|
229
|
+
cure --version
|
|
230
|
+
cure --help
|
|
231
|
+
```
|
|
187
232
|
|
|
188
233
|
## Programmatic API
|
|
189
234
|
|
|
@@ -192,167 +237,38 @@ import {
|
|
|
192
237
|
CancerTreatmentCapabilityModule,
|
|
193
238
|
createOncologyPlatform,
|
|
194
239
|
FHIRClient,
|
|
195
|
-
ClinicalTrialsGovClient
|
|
196
|
-
OutcomePredictorService,
|
|
197
|
-
DrugSafetyService,
|
|
198
|
-
HIPAAComplianceService
|
|
240
|
+
ClinicalTrialsGovClient
|
|
199
241
|
} from '@erosolaraijs/cure';
|
|
200
242
|
|
|
201
|
-
// Quick start
|
|
243
|
+
// Quick start
|
|
202
244
|
const platform = await createOncologyPlatform({
|
|
203
|
-
|
|
204
|
-
|
|
205
|
-
|
|
206
|
-
|
|
207
|
-
|
|
208
|
-
},
|
|
209
|
-
genomics: {
|
|
210
|
-
enabled: true,
|
|
211
|
-
platforms: ['foundation', 'guardant', 'tempus']
|
|
212
|
-
},
|
|
213
|
-
clinicalTrials: {
|
|
214
|
-
enabled: true,
|
|
215
|
-
maxDistance: 100
|
|
216
|
-
},
|
|
217
|
-
ml: {
|
|
218
|
-
enabled: true,
|
|
219
|
-
modelVersion: '1.0.0'
|
|
220
|
-
},
|
|
221
|
-
safety: {
|
|
222
|
-
enabled: true,
|
|
223
|
-
strictMode: true
|
|
224
|
-
},
|
|
225
|
-
compliance: {
|
|
226
|
-
enabled: true,
|
|
227
|
-
auditRetentionDays: 2555
|
|
228
|
-
}
|
|
245
|
+
genomics: { enabled: true, platforms: ['foundation', 'guardant', 'tempus'] },
|
|
246
|
+
clinicalTrials: { enabled: true },
|
|
247
|
+
ml: { enabled: true },
|
|
248
|
+
safety: { enabled: true, strictMode: true },
|
|
249
|
+
compliance: { enabled: true }
|
|
229
250
|
});
|
|
230
251
|
|
|
231
|
-
// Generate comprehensive treatment plan
|
|
232
|
-
const plan = await platform.generateComprehensivePlan(patient, 'DR001');
|
|
233
|
-
```
|
|
234
|
-
|
|
235
|
-
### Core Module Usage
|
|
236
|
-
|
|
237
|
-
```typescript
|
|
238
|
-
// Cancer treatment capability
|
|
239
|
-
const capability = new CancerTreatmentCapabilityModule();
|
|
240
|
-
|
|
241
|
-
// Analyze patient
|
|
242
|
-
const analysis = await capability.analyzePatient('P001', true);
|
|
243
|
-
|
|
244
252
|
// Generate cure protocol
|
|
245
|
-
const cure = await
|
|
253
|
+
const cure = await platform.cureCancer('P001', 'Lung', 'IV', {
|
|
246
254
|
mutations: ['EGFR', 'TP53'],
|
|
247
255
|
biomarkers: ['PD-L1'],
|
|
248
256
|
msiStatus: 'MSS',
|
|
249
257
|
tmbLevel: 'High'
|
|
250
258
|
});
|
|
251
|
-
|
|
252
|
-
// Discover drug targets
|
|
253
|
-
const targets = await capability.discoverDrugTargets('Melanoma', 'BRAF');
|
|
254
|
-
```
|
|
255
|
-
|
|
256
|
-
### Individual Services
|
|
257
|
-
|
|
258
|
-
```typescript
|
|
259
|
-
// EHR Integration
|
|
260
|
-
const fhir = new FHIRClient(config);
|
|
261
|
-
const patient = await fhir.getPatient('12345');
|
|
262
|
-
const conditions = await fhir.getConditions('12345');
|
|
263
|
-
|
|
264
|
-
// Clinical Trials
|
|
265
|
-
const trials = new ClinicalTrialsGovClient();
|
|
266
|
-
const matches = await trials.searchTrials({
|
|
267
|
-
condition: 'Non-Small Cell Lung Cancer',
|
|
268
|
-
intervention: 'pembrolizumab',
|
|
269
|
-
status: 'RECRUITING'
|
|
270
|
-
});
|
|
271
|
-
|
|
272
|
-
// ML Predictions
|
|
273
|
-
const predictor = new OutcomePredictorService();
|
|
274
|
-
const response = await predictor.predictResponse(patientFeatures, treatmentFeatures);
|
|
275
|
-
|
|
276
|
-
// Drug Safety
|
|
277
|
-
const safety = new DrugSafetyService();
|
|
278
|
-
const interactions = await safety.checkInteractions(['pembrolizumab', 'ipilimumab']);
|
|
279
|
-
|
|
280
|
-
// HIPAA Compliance
|
|
281
|
-
const hipaa = new HIPAAComplianceService();
|
|
282
|
-
await hipaa.logAccess(userId, patientId, 'VIEW', 'Clinical review');
|
|
283
259
|
```
|
|
284
260
|
|
|
285
261
|
## Environment Variables
|
|
286
262
|
|
|
287
263
|
| Variable | Description |
|
|
288
264
|
|----------|-------------|
|
|
289
|
-
| `AI_PROVIDER` |
|
|
265
|
+
| `AI_PROVIDER` | `xai` or `openai` (default: xai) |
|
|
290
266
|
| `XAI_API_KEY` | xAI API key |
|
|
291
267
|
| `OPENAI_API_KEY` | OpenAI API key |
|
|
292
268
|
| `FHIR_BASE_URL` | FHIR server URL |
|
|
293
269
|
| `FHIR_CLIENT_ID` | FHIR OAuth client ID |
|
|
294
270
|
| `FHIR_CLIENT_SECRET` | FHIR OAuth client secret |
|
|
295
271
|
|
|
296
|
-
## Supported Cancer Types
|
|
297
|
-
|
|
298
|
-
<details>
|
|
299
|
-
<summary>Click to expand full list</summary>
|
|
300
|
-
|
|
301
|
-
**Solid Tumors:**
|
|
302
|
-
- Lung (NSCLC, SCLC, mesothelioma)
|
|
303
|
-
- Breast (HR+, HER2+, TNBC)
|
|
304
|
-
- Colorectal
|
|
305
|
-
- Prostate
|
|
306
|
-
- Melanoma
|
|
307
|
-
- Pancreatic
|
|
308
|
-
- Hepatocellular
|
|
309
|
-
- Gastric/Esophageal
|
|
310
|
-
- Ovarian
|
|
311
|
-
- Endometrial
|
|
312
|
-
- Cervical
|
|
313
|
-
- Bladder/Urothelial
|
|
314
|
-
- Renal Cell
|
|
315
|
-
- Head and Neck
|
|
316
|
-
- Thyroid
|
|
317
|
-
- Sarcomas
|
|
318
|
-
- Brain (GBM, meningioma)
|
|
319
|
-
- And 150+ more subtypes
|
|
320
|
-
|
|
321
|
-
**Hematologic Malignancies:**
|
|
322
|
-
- Acute Myeloid Leukemia (AML)
|
|
323
|
-
- Acute Lymphoblastic Leukemia (ALL)
|
|
324
|
-
- Chronic Myeloid Leukemia (CML)
|
|
325
|
-
- Chronic Lymphocytic Leukemia (CLL)
|
|
326
|
-
- Diffuse Large B-Cell Lymphoma
|
|
327
|
-
- Follicular Lymphoma
|
|
328
|
-
- Hodgkin Lymphoma
|
|
329
|
-
- Multiple Myeloma
|
|
330
|
-
- Myelodysplastic Syndromes
|
|
331
|
-
- Myeloproliferative Neoplasms
|
|
332
|
-
|
|
333
|
-
**Rare Cancers:**
|
|
334
|
-
- Cholangiocarcinoma
|
|
335
|
-
- Neuroendocrine Tumors
|
|
336
|
-
- GIST
|
|
337
|
-
- Adrenocortical Carcinoma
|
|
338
|
-
- Thymoma
|
|
339
|
-
- And more
|
|
340
|
-
|
|
341
|
-
</details>
|
|
342
|
-
|
|
343
|
-
## Emerging Therapeutics
|
|
344
|
-
|
|
345
|
-
The platform includes cutting-edge treatment modalities:
|
|
346
|
-
|
|
347
|
-
- **Antibody-Drug Conjugates (ADCs):** T-DXd, sacituzumab govitecan
|
|
348
|
-
- **Bispecific Antibodies:** teclistamab, glofitamab
|
|
349
|
-
- **CAR-T Therapies:** axi-cel, liso-cel, ide-cel
|
|
350
|
-
- **Tumor-Infiltrating Lymphocytes (TILs):** lifileucel
|
|
351
|
-
- **KRAS Inhibitors:** sotorasib, adagrasib
|
|
352
|
-
- **Protein Degraders:** PROTACs, molecular glues
|
|
353
|
-
- **Radiopharmaceuticals:** Lu-177 PSMA, I-131 MIBG
|
|
354
|
-
- **Cancer Vaccines:** mRNA-4157, personalized neoantigen vaccines
|
|
355
|
-
|
|
356
272
|
## Requirements
|
|
357
273
|
|
|
358
274
|
- Node.js >= 18.0.0
|
|
@@ -364,4 +280,3 @@ MIT
|
|
|
364
280
|
## Links
|
|
365
281
|
|
|
366
282
|
- [npm Package](https://www.npmjs.com/package/@erosolaraijs/cure)
|
|
367
|
-
- [Report Issues](https://github.com/anthropics/claude-code/issues)
|
package/dist/bin/cure.js
CHANGED
|
@@ -20,7 +20,7 @@ import * as os from 'os';
|
|
|
20
20
|
import { CancerTreatmentCapabilityModule } from '../capabilities/cancerTreatmentCapability.js';
|
|
21
21
|
import { createRealWorldOncologyService } from '../orchestrator/realWorldOncology.js';
|
|
22
22
|
import { getCliTool, listCliTools } from '../tools/index.js';
|
|
23
|
-
const VERSION = '2.
|
|
23
|
+
const VERSION = '2.5.1';
|
|
24
24
|
const PACKAGE_NAME = '@erosolaraijs/cure';
|
|
25
25
|
const UPDATE_CHECK_INTERVAL = 24 * 60 * 60 * 1000; // 24 hours
|
|
26
26
|
let currentProvider = process.env.AI_PROVIDER || 'xai';
|
|
@@ -1 +1 @@
|
|
|
1
|
-
{"version":3,"file":"index.d.ts","sourceRoot":"","sources":["../../src/tools/index.ts"],"names":[],"mappings":"AAAA,OAAO,EAAE,+BAA+B,EAAE,MAAM,8CAA8C,CAAC;AAoB/F,OAAO,EACL,wBAAwB,EAExB,KAAK,eAAe,EAErB,MAAM,sCAAsC,CAAC;AAkB9C,MAAM,WAAW,WAAW;IAC1B,eAAe,EAAE,+BAA+B,CAAC;IACjD,eAAe,CAAC,EAAE,wBAAwB,GAAG,IAAI,CAAC;IAClD,aAAa,CAAC,EAAE,OAAO,CAAC,eAAe,CAAC,CAAC;CAC1C;AAED,MAAM,WAAW,SAAS;IACxB,IAAI,EAAE,MAAM,CAAC;IACb,EAAE,EAAE,OAAO,CAAC;IACZ,MAAM,CAAC,EAAE,MAAM,CAAC;CACjB;AAED,MAAM,WAAW,UAAU;IACzB,MAAM,EAAE,MAAM,CAAC;IACf,EAAE,EAAE,OAAO,CAAC;IACZ,OAAO,EAAE,MAAM,CAAC;IAChB,UAAU,EAAE,MAAM,CAAC;IACnB,MAAM,CAAC,EAAE,SAAS,EAAE,CAAC;IACrB,OAAO,CAAC,EAAE,MAAM,CAAC,MAAM,EAAE,MAAM,GAAG,MAAM,CAAC,CAAC;CAC3C;AAED,MAAM,WAAW,iBAAiB;IAChC,EAAE,EAAE,MAAM,CAAC;IACX,WAAW,EAAE,MAAM,CAAC;IACpB,KAAK,EAAE,MAAM,CAAC;IACd,GAAG,EAAE,CAAC,OAAO,EAAE,WAAW,EAAE,IAAI,EAAE,MAAM,EAAE,KAAK,OAAO,CAAC,UAAU,CAAC,CAAC;CACpE;AA8lBD,wBAAsB,gBAAgB,CAAC,OAAO,EAAE,WAAW,GAAG,OAAO,CAAC,UAAU,CAAC,CA2FhF;AAED,wBAAsB,mBAAmB,IAAI,OAAO,CAAC,UAAU,CAAC,CAqC/D;
|
|
1
|
+
{"version":3,"file":"index.d.ts","sourceRoot":"","sources":["../../src/tools/index.ts"],"names":[],"mappings":"AAAA,OAAO,EAAE,+BAA+B,EAAE,MAAM,8CAA8C,CAAC;AAoB/F,OAAO,EACL,wBAAwB,EAExB,KAAK,eAAe,EAErB,MAAM,sCAAsC,CAAC;AAkB9C,MAAM,WAAW,WAAW;IAC1B,eAAe,EAAE,+BAA+B,CAAC;IACjD,eAAe,CAAC,EAAE,wBAAwB,GAAG,IAAI,CAAC;IAClD,aAAa,CAAC,EAAE,OAAO,CAAC,eAAe,CAAC,CAAC;CAC1C;AAED,MAAM,WAAW,SAAS;IACxB,IAAI,EAAE,MAAM,CAAC;IACb,EAAE,EAAE,OAAO,CAAC;IACZ,MAAM,CAAC,EAAE,MAAM,CAAC;CACjB;AAED,MAAM,WAAW,UAAU;IACzB,MAAM,EAAE,MAAM,CAAC;IACf,EAAE,EAAE,OAAO,CAAC;IACZ,OAAO,EAAE,MAAM,CAAC;IAChB,UAAU,EAAE,MAAM,CAAC;IACnB,MAAM,CAAC,EAAE,SAAS,EAAE,CAAC;IACrB,OAAO,CAAC,EAAE,MAAM,CAAC,MAAM,EAAE,MAAM,GAAG,MAAM,CAAC,CAAC;CAC3C;AAED,MAAM,WAAW,iBAAiB;IAChC,EAAE,EAAE,MAAM,CAAC;IACX,WAAW,EAAE,MAAM,CAAC;IACpB,KAAK,EAAE,MAAM,CAAC;IACd,GAAG,EAAE,CAAC,OAAO,EAAE,WAAW,EAAE,IAAI,EAAE,MAAM,EAAE,KAAK,OAAO,CAAC,UAAU,CAAC,CAAC;CACpE;AA8lBD,wBAAsB,gBAAgB,CAAC,OAAO,EAAE,WAAW,GAAG,OAAO,CAAC,UAAU,CAAC,CA2FhF;AAED,wBAAsB,mBAAmB,IAAI,OAAO,CAAC,UAAU,CAAC,CAqC/D;AAioFD,wBAAgB,YAAY,IAAI,iBAAiB,EAAE,CAElD;AAED,wBAAgB,UAAU,CAAC,EAAE,EAAE,MAAM,GAAG,iBAAiB,GAAG,SAAS,CAEpE"}
|